nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Contents
|
|
|
|
18 |
4 |
p. vii-ix |
artikel |
2 |
Contributors
|
|
|
|
18 |
4 |
p. iii-v |
artikel |
3 |
Copyright
|
|
|
|
18 |
4 |
p. ii |
artikel |
4 |
Forthcoming Issues
|
|
|
|
18 |
4 |
p. x |
artikel |
5 |
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors
|
Mordi, Ify R. |
|
|
18 |
4 |
p. 529-538 |
artikel |
6 |
Renoprotective Effects of SGLT2 Inhibitors
|
Vallon, Volker |
|
|
18 |
4 |
p. 539-549 |
artikel |
7 |
SGLT-2 Inhibitors
|
Baliga, Ragavendra R. |
|
|
18 |
4 |
p. i |
artikel |
8 |
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction
|
Jhund, Pardeep S. |
|
|
18 |
4 |
p. 579-586 |
artikel |
9 |
SGLT2 Inhibitors and Peripheral Vascular Events
|
Marchiori, Elena |
|
|
18 |
4 |
p. 609-623 |
artikel |
10 |
SGLT2 Inhibitors and Safety in Older Patients
|
Pollack, Rena |
|
|
18 |
4 |
p. 635-643 |
artikel |
11 |
SGLT2 Inhibitors Are Lifesavers in Heart Failure
|
Baliga, Ragavendra R. |
|
|
18 |
4 |
p. xi-xiv |
artikel |
12 |
SGLT2 Inhibitors in Heart Failure
|
Dixit, Neal M. |
|
|
18 |
4 |
p. 587-596 |
artikel |
13 |
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction
|
Rastogi, Tripti |
|
|
18 |
4 |
p. 561-577 |
artikel |
14 |
SGLT2 Inhibitors in Type 2 Diabetes Mellitus
|
Ferrannini, Giulia |
|
|
18 |
4 |
p. 551-559 |
artikel |
15 |
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk
|
Arnott, Clare |
|
|
18 |
4 |
p. 645-654 |
artikel |
16 |
Sodium-glucose Cotransporter 2 Inhibitors and Nonalcoholic Fatty Liver Disease
|
Salah, Husam M. |
|
|
18 |
4 |
p. 625-634 |
artikel |
17 |
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events
|
Nelson, Adam J. |
|
|
18 |
4 |
p. 597-607 |
artikel |